{"name":"Metamizole","slug":"metamizole","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Metamizol","Methamizole","Novamine sulfone","Methamizole-","(antipyrinylmethylamino)methanesulfonic acid","Methanesulfonic acid, (antipyrinylmethylamino)-","N-Methyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)aminomethanesulfosaeure","Dolemicin","256-627-7","Metamizolum"],"brands":[],"scraped":true,"has_structure":true,"cid":3111,"classes":[{"name":"analgesic","href":"/class/analgesic"},{"name":"antipyretics","href":"/class/antipyretics"},{"name":"cyp3a4 inducer","href":"/class/cyp3a4_inducer"}],"families":[{"name":"aniline","href":"/substituted/aniline"}],"physical":[{"label":"Molecular mass","value":"311.36 g/mol","copyable":false},{"label":"Predicted LogP","value":"0","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S","copyable":true},{"label":"IUPAC name","value":"[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonic acid","copyable":true},{"label":"SMILES","value":"CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)O","copyable":true},{"label":"InChI","value":"InChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)","copyable":true},{"label":"InChIKey","value":"LVWZTYCIRDMTEY-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"50567-35-6","copyable":true},{"label":"UNII","value":"934T64RMNJ","copyable":true},{"label":"PubChem CID","value":"3111","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"14 minutes (parent compound; IV route); metabolites: 2–4 hour","copyable":false},{"label":"Duration of action","value":"4–6 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Urine (96%, IV; 85%, oral), faeces (4%, IV).","copyable":false},{"label":"Routes of administration","value":"By mouth, intramuscular, intravenous, rectal","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Sodium metamizole","name":"sodium","slug":"sodium_metamizole","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"The mechanism of action of metamizole is not fully understood. Its active metabolites, 4-methyl-amino-antipyrine (MAA) and 4-amino-antipyrine (AA), inhibit prostaglandin E2 (PGE<sub>2</sub>)-induced hyperalgesia. It has been suggested that the anti-hyperalgesic effect of MAA is mediated by guanosine 3',5'-cyclic monophosphate (cGMP) activation and ATP-sensitive potassium channel opening, while the effects of AA are associated with the activation of cannabinoid receptor type 1 (CB1). Metamizole is classified in some sources as a weak non-steroidal anti-inflammatory drug (NSAID); however, evidence suggests that its analgesic effects do not depend on its anti-inflammatory properties. Although the inhibition of cyclooxygenase (COX) 2 may play a role in the central nervous system effects of metamizole, reports suggest that metamizole inhibits COX-3 with a higher affinity compared to COX-1 or COX-2.","side_effects":null,"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Metamizole","composite":false,"routes":[{"name":"Oral","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["effects not notable"]}},{"user":"alina","user_slug":"alina","external":false,"note":{"substance":"Metamizole","composite":false,"routes":[{"name":"oral","dosage":"250-500mg","onset":null,"comeup":null,"duration":null,"active":null},{"name":"intravenous","dosage":"1000mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"emily","user_slug":"emily","external":false,"note":{"substance":"Metamizole","composite":false,"routes":[{"name":"oral","dosage":"500mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"Pilz","user_slug":"pilz","external":false,"note":{"substance":"Metamizole","composite":false,"routes":[{"name":"oral","dosage":"500mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":["sodium monohydrate"],"sources":["Polish Pharmacy: Pyralgina"],"indications":["{sev 'moderate'} pain"],"effects":["{sev 'moderate'} {xeff 'pain-relief'}, stronger than {sub 'Ibuprofen'}, but weaker than 150mg of {sub 'codeine'}"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["Helped with pain caused by {wkp 'Self-harm'}","Might help with stress induced muscle twitching"]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Withdrawn","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"OTC","act":null,"refs":[]},{"jurisdiction":"Canada","status":"Veterinary only","act":null,"refs":[3]},{"jurisdiction":"Germany","status":"Prescription only","act":null,"refs":[4]},{"jurisdiction":"New Zealand","status":"Prescription only","act":null,"refs":[5,6]},{"jurisdiction":"United Kingdom","status":"Withdrawn","act":null,"refs":[]},{"jurisdiction":"United States","status":"Veterinary only (horses)","act":null,"refs":[7]},{"jurisdiction":"European Union","status":"Legally available","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Metamizole"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/3111"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q56719288"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB04817"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL461522"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A62088"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=50567-35-6"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0254502"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D08188"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID6044143"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Metamizole"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/934T64RMNJ"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 3111, Metamizole. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/3111>https://pubchem.ncbi.nlm.nih.gov/compound/3111</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metamizole. UNII: 934T64RMNJ. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/934T64RMNJ>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/934T64RMNJ</a>","Notice of Amendment: Addition of Metamizole (Dipyrone) to the Prescription Drug List (PDL). Government of Canada. 2022-07-18. <a href='https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-metamizole.html'>https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-metamizole.html</a>","Risikoinformationen - Metamizol (Novalgin, Berlosin, Novaminsulfon, etc.): BfArM weist auf richtige Indikationsstellung und Beachtung von Vorsichtsmaßnahmen und Warnhinweisen hin. Bundesinstitut für Arzneimittel und Medizinprodukte (Federal Institute for Pharmaceuticals and Medical Products). 2009-05-28. <a href='https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2009/RI-metamizol.html'>https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2009/RI-metamizol.html</a>","Recent NZ Gazette Notices Relating to Classification. medsafe.govt.nz. 2020-03-06. <a href='https://www.medsafe.govt.nz/profs/class/recent.asp'>https://www.medsafe.govt.nz/profs/class/recent.asp</a>","Minutes of the 63rd meeting of the Medicines Classification Committee - 10 Oct 2019. medsafe.govt.nz. 2019-12-04. <a href='https://www.medsafe.govt.nz/profs/class/Minutes/2016-2020/mccMin10Oct2019.htm'>https://www.medsafe.govt.nz/profs/class/Minutes/2016-2020/mccMin10Oct2019.htm</a>","Zimeta (dipyrone injection) - Veterinarians. FDA. November 26, 2019. <a href='https://www.fda.gov/animal-veterinary/product-safety-information/zimeta-dipyrone-injection-veterinarians'>https://www.fda.gov/animal-veterinary/product-safety-information/zimeta-dipyrone-injection-veterinarians</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 10:24:51","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 10:24:47","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 10:24:47","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 10:24:48","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 10:24:47","note":"hmdb.ca refused automated access to HMDB0254502"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 10:24:48","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 10:24:47","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 10:24:47","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 10:24:47","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 10:24:47","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 10:24:47","note":null}],"description":"Metamizole is a analgesic, antipyretics, cyp3a4 inducer substance."}